Last reviewed · How we verify
NCT04091906
PBMC Donation in UCAR-T Cells
NA trial testing Peripheral blood mononuclear cell apheresis in Peripheral Blood Mononuclear Cell Donation in 20 participants. Status unknown.
31 March 2020
Quick facts
| Lead sponsor | The First Affiliated Hospital with Nanjing Medical University |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | other |
| Enrollment | 20 |
| Start date | 1 October 2019 |
| Primary completion | 31 March 2020 |
| Estimated completion | 30 June 2020 |
| Sites | 1 location across China |
Drugs / interventions tested
- Peripheral blood mononuclear cell apheresis
Conditions studied
- Peripheral Blood Mononuclear Cell Donation — all drugs for Peripheral Blood Mononuclear Cell Donation →
Sponsor
The First Affiliated Hospital with Nanjing Medical University
Who can join
Adults 18 to 40, any sex, with Peripheral Blood Mononuclear Cell Donation. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Peripheral blood mononuclear cell donation protocol for tumor immunotherapy study of UCAR-T cells
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04091906
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Peripheral blood mononuclear cell apheresis
Trials testing the same drug.
- NCT04963959 — PBMC Collection for Production of UCAR T Cells · NA · unknown
- NCT04448509 — Peripheral Blood Mononuclear Cell Collection Protocol for UCART Cell Tumor Immunotherapy Study · NA · unknown
Other The First Affiliated Hospital with Nanjing Medical University trials
Trials by the same sponsor.
- NCT07377981 — An Exploratory Study of the Efficacy and Safety of Esketamine and Dexmedetomidine in Non-Intubated ICU Patients With Hyp · Phase 4 · not yet recruiting
- NCT07523789 — Comparison of Chemotherapy and Immunotherapy in Neoadjuvant Therapy for TNBC · not yet recruiting
- NCT07464756 — SHR-1701 With or Without Apatinib in Combination With Chemotherapy as Neoadjuvant Therapy for Gastric Cancer · Phase 2 · not yet recruiting
- NCT07482826 — Full-Endoscopic Decompression vs. Endoscopic Lumbar Fusion for Middle-Aged and Older Adults With Spinal Stenosis · NA · not yet recruiting
- NCT07558863 — Effect of GLP-1RA on Cardiac Autonomic Neuropathy in Type 2 Diabetes · Phase 4 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04091906 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by The First Affiliated Hospital with Nanjing Medical University
- Last refreshed: 17 September 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04091906.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing